[{"indications": "Indications\u00a0see notes above and under Dose", "name": "MISOPROSTOL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.3 Antisecretory drugs and mucosal protectants", "1.3.4 Prostaglandin analogues", "MISOPROSTOL"], "cautions": "Cautions\u00a0inflammatory bowel disease; conditions where hypotension might precipitate severe\r\ncomplications (e.g. cerebrovascular disease, cardiovascular disease)", "side-effects": "Side-effects\u00a0diarrhoea (may occasionally be severe and require\r\nwithdrawal, reduced by giving single doses not exceeding 200\u00a0micrograms\r\nand by avoiding magnesium-containing antacids); also reported: abdominal\r\npain, dyspepsia, flatulence, nausea and vomiting, abnormal vaginal\r\nbleeding (including intermenstrual bleeding, menorrhagia, and postmenopausal\r\nbleeding), rashes, dizziness", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2135.htm", "doses": ["Benign gastric and duodenal ulceration and NSAID-associated\r\nulceration, adult over 18 years, 800\u00a0micrograms\r\ndaily (in 2\u20134 divided doses) with breakfast (or main meals) and at\r\nbedtime; treatment should be continued for at least 4 weeks and may\r\nbe continued for up to 8 weeks if required", "Prophylaxis of NSAID-induced gastric and duodenal ulcer, adult over 18 years, 200\u00a0micrograms 4 times daily\r\n(if not tolerated, reduced to 200\u00a0micrograms 2\u20133 times daily, but\r\nless effective)"], "pregnancy": "Pregnancy\u00a0avoid\u2014potent uterine stimulant (has been used to\r\ninduce abortion); teratogenic risk in first trimester; important: see also Women of Childbearing Age, above"}]